GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Increased
Reduced
Net increased
Funds Holding
2,567
Funds Holding Change
+10
Funds Holding Growth
+0.4%
Value
$522B
Holding in Top 10
616
Top 10 Change
-61
Top 10 Growth
-9%
Value Growth
+0.4%
New
107
Increased
1,031
Reduced
1,215
Closed
72
Capital Inflow
$19.1B
Capital Outflow
$20.2B
Net Capital Flow
-$1.16B
Capital Flow Change
-$5.52B
Calls
$7.66B
Puts
$6.84B
Net Calls
+$825M
Put/Call Ratio
0.89